Raza Ali | Researchain

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Raza Ali is active.

Explore More

Publication

Featured researches published by Raza Ali.

Archive | 2015

ΧΡΗΣΗ ΤΗΣ ROSUVASTATIN (ZD-4522) ΣΤΗ ΘΕΡΑΠΕΥΤΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΗΣ ΕΤΕΡΟΖΥΓΩΤΙΚΗΣ ΟΙΚΟΓΕΝΟΥΣ ΥΠΕΡΧΟΛΗΣΤΕΡΟΛΑΙΜΙΑΣ

Raza Ali; Hutchinson Howard Gerard

Archive | 2009

(E) - 7 - [4 - (4 - FLUOROPHENYL) - 6 - ISOPROPYL - 2 - [METHYL ( METHYLSULFONYL) AMINO] PYRIMIDIN - 5 - YL] (3R, 5S) - DIHYDROXYHEPT - 6 - ENOIC ACID, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE AS A MEDICAMENT FOR THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Raza Ali; Hutchinson Howard Gerard

Archive | 2008

Anvendelse af rosuvastatin (ZD-4522) til behandling af heterozygot, familiær hypercholesterolæmi

Raza Ali; Hutchinson Howard Gerard

Archive | 2008

Lyfjasamsetning sem samanstendur af (E)-7-[4-(4 fl·or¾fen²l)-6-Ýs¾pr¾p²l-2-[met²l(met²ls·lf¾n²l) amÝn¾]p²rimidÝn-5-²l](3R,5S)-3,5-dÝh²drox²hept-6-en¾s²ru og hindra, vaka e-a hvarfefni af P450 samsµtuensÝmi 3A4

Raza Ali; Pears John Stuart; Hutchinson Howard George; Schneck Dennis; Baba Takahiko; Touchi Akira; Yamaguchi Yoshitaka

Archive | 2008

USO DE ROSUVASTATINA (ZD-4522) EN EL TRATAMIENTO DE HIPERCOLESTEREMIA FAMILIAR HETEROCIGOTA.

Raza Ali; Hutchinson Howard Gerard

Archive | 2008

Anvendelse av et statin for fremstilling av et medikament ved behandling av heterozygot familiaer hyperkolesterolemi

Hutchinson Howard Gerard; Raza Ali

Archive | 2007

Non-interacting drug combination and pharmacy pack comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of P450 isoenzyme 3A4

Raza Ali; Pears John Stuart; Hutchinson Howard Geraro; Schneck Dennis; Baba Takahiko

Archive | 2007

Drug combination containing (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of p450 isozyme 3a4

Raza Ali; Pears John Stuart; Hutchinson Howard Gerard; Schneck Dennis; Baba Takahiko; Touchi Akira; Yamaguchi Yoshitaka

Archive | 2006

Farmasoytisk medikament-kombinasjoner omfattende (E)-7-[4-(4-fluorfenyl)-6-isopropyl-2-[metyl-(metylsulfonyl)-amino]-pyrimidin-5-yl]-(3R,5S)-3,5-dihydroksy-hept-6-ensyre og en inhibitor, inducer eller substrat av P450 isoenzym 3A4 samt anvendelse derav

Raza Ali; Pears John Stuart; Hutchinson Howard Gerard; Baba Takahiko; Schneck Dennis; Touchi Akira; Yamaguchi Yoshitaka

Archive | 2005

Pharmaceutical composition for use in the treatment of heterozygous familial hypercholesterolemia

Raza Ali; Hutchinson Howard Gerard

Explore More

Collaboration

Dive into the Raza Ali's collaboration.

Top Co-Authors

Hutchinson Howard Gerard

AstraZeneca

View shared research outputs

Explore More

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot

Dive into the research topics where Raza Ali is active.

Publication

Featured researches published by Raza Ali.

ΧΡΗΣΗ ΤΗΣ ROSUVASTATIN (ZD-4522) ΣΤΗ ΘΕΡΑΠΕΥΤΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΗΣ ΕΤΕΡΟΖΥΓΩΤΙΚΗΣ ΟΙΚΟΓΕΝΟΥΣ ΥΠΕΡΧΟΛΗΣΤΕΡΟΛΑΙΜΙΑΣ

(E) - 7 - [4 - (4 - FLUOROPHENYL) - 6 - ISOPROPYL - 2 - [METHYL ( METHYLSULFONYL) AMINO] PYRIMIDIN - 5 - YL] (3R, 5S) - DIHYDROXYHEPT - 6 - ENOIC ACID, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE AS A MEDICAMENT FOR THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Anvendelse af rosuvastatin (ZD-4522) til behandling af heterozygot, familiær hypercholesterolæmi

Lyfjasamsetning sem samanstendur af (E)-7-[4-(4 fl·or¾fen²l)-6-Ýs¾pr¾p²l-2-[met²l(met²ls·lf¾n²l) amÝn¾]p²rimidÝn-5-²l](3R,5S)-3,5-dÝh²drox²hept-6-en¾s²ru og hindra, vaka e-a hvarfefni af P450 samsµtuensÝmi 3A4

USO DE ROSUVASTATINA (ZD-4522) EN EL TRATAMIENTO DE HIPERCOLESTEREMIA FAMILIAR HETEROCIGOTA.

Anvendelse av et statin for fremstilling av et medikament ved behandling av heterozygot familiaer hyperkolesterolemi

Non-interacting drug combination and pharmacy pack comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of P450 isoenzyme 3A4

Drug combination containing (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of p450 isozyme 3a4

Farmasoytisk medikament-kombinasjoner omfattende (E)-7-[4-(4-fluorfenyl)-6-isopropyl-2-[metyl-(metylsulfonyl)-amino]-pyrimidin-5-yl]-(3R,5S)-3,5-dihydroksy-hept-6-ensyre og en inhibitor, inducer eller substrat av P450 isoenzym 3A4 samt anvendelse derav

Pharmaceutical composition for use in the treatment of heterozygous familial hypercholesterolemia

Collaboration

Dive into the Raza Ali's collaboration.